U-Neuron Biomedical Inc.

U-Neuron Biomedical Inc. is a biotechnology company established in 2015 and based in New Taipei City, Taiwan. Its principal focus is on the research and development of cell therapy technologies, particularly those related to stem cell storage, isolation, and application. The company holds patents in amniotic fluid stem cell culture technology and develops both autologous and allogeneic stem cell products, with a notable application being the treatment of stroke through autologous stem cell transplantation. U-Neuron Biomedical’s portfolio encompasses a range of products, including amniotic fluid and adipose stem cells for clinical use, as well as domestically marketed consumer goods such as medical beauty and health care cosmetics. These consumer products leverage the regenerative properties of deer amniotic fluid stem cell derivatives and include items like anti-aging masks, essences, and creams. In the field of pharmaceuticals, the company is advancing novel treatments, with candidates such as UA002 for erectile dysfunction and UB003 for dry eye. U-Neuron Biomedical Inc. plays a specialized role in Taiwan’s biotechnology sector, advancing both therapeutic innovations and consumer-focused healthcare solutions built on its proprietary stem cell technologies.